Form 4: Marathon Bancorp Director Amy Zientara Equity Grant

Sentiment:

Director Equity Grant


Chairwoman Amy Zientara acquired 3,386 shares of restricted stock and 8,467 stock options in Marathon Bancorp, Inc.

Summary

  • Chairwoman of the Board Amy Zientara was granted 3,386 shares of restricted stock on June 15, 2026.
  • The reporting person also received 8,467 stock options with an exercise price of $14.55.
  • The restricted stock and new stock options vest at a rate of 20% per year, beginning June 15, 2027.
  • Following these transactions, the reporting person holds 27,110 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation, which does not signal a change in company strategy or financial performance.

Positives

  • Alignment of interests between the Chairwoman and shareholders through equity-based compensation.
  • Long-term retention incentive created by the 5-year vesting schedule (20% per year).

Negatives

  • Potential for future dilution of existing shareholders upon the exercise of stock options.

Risks

  • Market price volatility affecting the value of the granted equity.
  • Performance risk associated with the company's ability to maintain share price above the $14.55 exercise price for the new options.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on director compensation and equity ownership changes.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard practice in the banking sector to ensure long-term alignment with shareholder interests and to incentivize board oversight.

Comparison to Industry Standards

  • The use of 5-year vesting schedules (20% per year) is consistent with standard corporate governance practices for regional banking institutions.
  • Granting a mix of restricted stock and options is a common compensation structure for non-executive directors.

Stakeholder Impact

  • Shareholders may experience minor dilution upon the eventual exercise of the granted stock options.

Next Steps

  • Vesting of restricted stock and options to commence on June 15, 2027.

Key Dates

DateDescription
06/28/2023Vesting commencement for previous stock options.
05/16/2024Vesting commencement for previous stock options.
06/15/2026Transaction date for new restricted stock and option grants.
06/16/2026Filing date of the Form 4.
06/15/2027Vesting commencement for new restricted stock and options.
06/15/2036Expiration date for new stock options.

Keywords

Marathon Bancorp, MBBC, Insider Trading, Form 4, Equity Compensation, Director Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.